Adjunct Professor of Surgery
Feinberg School of Medicine
Donald E. Fry serves on the board of the Surgical Infection Foundation and is a past president of the organization. He is currently a member of 25 surgical societies and held no offices for any of these societies at the time of publication. He is editor-in-chief of the journal Surgical Infections. He speaks periodically on surgical infections for Becton Dickinson. He is a consultant to Prescient Surgical Co. (wound protector; stock options) and Melinta Therapeutics (new antibiotic; honorarium). He is a consultant and chairperson of the advisory board to the IrrlMax Company (honorarium; research funding) on the use of an application of dilute chlorhexidine in the surgical wound.